Literature DB >> 12626433

Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.

Francis J Descamps1, Philippe E Van den Steen, Erik Martens, Florence Ballaux, Karel Geboes, Ghislain Opdenakker.   

Abstract

Genetic, endocrine, and environmental factors contribute to the development of diabetes. Much information has been gathered on the homeostasis mechanisms of glucose regulation by insulin-producing pancreatic beta cells. Here we demonstrate high expression levels of gelatinase B (matrix metalloproteinase-9, MMP-9) by neutrophils in acute pancreatitis and by ductular epithelial cells in chronic pancreatitis. Because gelatinase B processes cytokines and chemokines, we investigated whether and how gelatinase B cleaves insulin. Pure human neutrophil gelatinase B was found to destroy insulin by cleavage at 10 sites. Pancreatic islet and ductular cells are relatively spared in comparison with the complete destruction of acinar cells of the exocrine pancreas in chronic pancreatitis. High expression levels of gelatinase B are maintained in the immediate proximity of insulin-secreting beta cells. Consequently, diabetes may be worsened by enzymatic degradation of insulin by gelatinase B and by the consequent enhancement of the autoimmune process. Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626433     DOI: 10.1096/fj.02-0725fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice.

Authors:  Diane M Jaworski; Olga Sideleva; Holly M Stradecki; Garret D Langlois; Aida Habibovic; Basanthi Satish; William G Tharp; James Lausier; Kyla Larock; Thomas L Jetton; Mina Peshavaria; Richard E Pratley
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

2.  Altered plasma matrix metalloproteinase-9/tissue inhibitor of matrix [corrected] metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer.

Authors:  I Kirman; S Jain; V Cekic; A Belizon; E Balik; P Sylla; T Arnell; K A Forde; R L Whelan
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

Review 3.  Acute recurrent pancreatitis: an autoimmune disease?

Authors:  Raffaele Pezzilli
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

4.  Role of Plasma MMP 9 levels in the Pathogenesis of Chronic Pancreatitis.

Authors:  A Venkateshwari; K Sri Manjari; D Krishnaveni; Pratibha Nallari; A Vidyasagar; A Jyothy
Journal:  Indian J Clin Biochem       Date:  2011-01-08

Review 5.  The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge.

Authors:  Xi Ping Zhang; Lei Wang; Yi Feng Zhou
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

Review 6.  Study progress on mechanism of severe acute pancreatitis complicated with hepatic injury.

Authors:  Xi-ping Zhang; Lei Wang; Jie Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

7.  MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.

Authors:  Estefania Ugarte-Berzal; Lise Boon; Erik Martens; Vasily Rybakin; Daniel Blockmans; Jennifer Vandooren; Paul Proost; Ghislain Opdenakker
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

8.  Characterisation of the fibroinflammatory process involved in progression from acute to chronic pancreatitis: study protocol for a multicentre, prospective cohort study.

Authors:  Srdan Novovic; Anders Borch; Mikkel Werge; David Karran; Lise Gluud; Palle Nordblad Schmidt; Erik Feldager Hansen; Camilla Nøjgaard; Annette Bøjer Jensen; Frank Krieger Jensen; Jens Brøndum Frøkjær; Mark Berner Hansen; Lars Nannestad Jørgensen; Asbjørn Mohr Drewes; Søren Schou Olesen
Journal:  BMJ Open       Date:  2019-08-21       Impact factor: 2.692

9.  Inhibition of gelatinase B (matrix metalloprotease-9) activity reduces cellular inflammation and restores function of transplanted pancreatic islets.

Authors:  Neelam Lingwal; Manju Padmasekar; Balaji Samikannu; Reinhard G Bretzel; Klaus T Preissner; Thomas Linn
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

10.  The Toll-like receptor 4 antagonist TAK-242 protects against chronic pancreatitis in rats.

Authors:  Long-Fei Pan; Lei Yu; Li-Ming Wang; Jun-Tao He; Jiang-Li Sun; Xiao-Bo Wang; Zheng-Hai Bai; Hai Wang; Ting-Lin Yan; Hong-Hong Pei
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.